Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Yarranton

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
British Journal of Haematology|April 2, 2005
Criteria for defining a complete remission in acute myeloid leukaemiaHelen Yarranton
Current Opinion in Neurology|July 15, 2003
An update on the pathogenesis and management of acquired thrombotic thrombocytopenic purpuraHelen Yarranton, Samuel J Machin
Acute Medicine|May 26, 2011
Initial treatment of pulmonary embolismAlastair Proudfoot, Helen Yarranton, Simon Gibbs, et al.
Acta Dermato-Venereologica|September 3, 2013
Urticarial vasculitis associated with essential thrombocythaemiaAnnabel D Scott, Nicholas Francis, Helen Yarranton, et al.
AIDS (London, England)|June 3, 2015
Serum-free light chains in HIV-associated lymphoma: no correlation with histology or prognosisVictoria Tittle, Michael Rayment, Emma Keeling, et al.
British Journal of Haematology|June 5, 2003
Venous thromboembolism associated with the management of acute thrombotic thrombocytopenic purpuraHelen Yarranton, Hannah Cohen, Sue R Pavord, et al.
Transfusion|September 1, 2005
Coagulation factor levels in cryosupernatant prepared from plasma treated with amotosalen hydrochloride (S-59) and ultraviolet A lightHelen Yarranton, Andrew S Lawrie, Ian J Mackie, et al.
British Journal of Haematology|July 22, 2008
Regional UK TTP registry: correlation with laboratory ADAMTS 13 analysis and clinical featuresMarie Scully, Helen Yarranton, Ri Liesner, et al.
Hematological Oncology|March 17, 2012
Gemcitabine and vinorelbine chemotherapy for refractory or relapsing aggressive non-Hodgkin lymphomaVanessa Sivam, Lucy Cook, George Hughes, et al.
Blood|November 22, 2012
Clinical drug resistance linked to interconvertible phenotypic and functional states of tumor-propagating cells in multiple myelomaAristeidis Chaidos, Chris P Barnes, Gillian Cowan, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
British Journal of Haematology|April 2, 2005
Criteria for defining a complete remission in acute myeloid leukaemiaHelen Yarranton
Current Opinion in Neurology|July 15, 2003
An update on the pathogenesis and management of acquired thrombotic thrombocytopenic purpuraHelen Yarranton, Samuel J Machin
Acute Medicine|May 26, 2011
Initial treatment of pulmonary embolismAlastair Proudfoot, Helen Yarranton, Simon Gibbs, et al.
Acta Dermato-Venereologica|September 3, 2013
Urticarial vasculitis associated with essential thrombocythaemiaAnnabel D Scott, Nicholas Francis, Helen Yarranton, et al.
AIDS (London, England)|June 3, 2015
Serum-free light chains in HIV-associated lymphoma: no correlation with histology or prognosisVictoria Tittle, Michael Rayment, Emma Keeling, et al.
British Journal of Haematology|June 5, 2003
Venous thromboembolism associated with the management of acute thrombotic thrombocytopenic purpuraHelen Yarranton, Hannah Cohen, Sue R Pavord, et al.
Transfusion|September 1, 2005
Coagulation factor levels in cryosupernatant prepared from plasma treated with amotosalen hydrochloride (S-59) and ultraviolet A lightHelen Yarranton, Andrew S Lawrie, Ian J Mackie, et al.
British Journal of Haematology|July 22, 2008
Regional UK TTP registry: correlation with laboratory ADAMTS 13 analysis and clinical featuresMarie Scully, Helen Yarranton, Ri Liesner, et al.
Hematological Oncology|March 17, 2012
Gemcitabine and vinorelbine chemotherapy for refractory or relapsing aggressive non-Hodgkin lymphomaVanessa Sivam, Lucy Cook, George Hughes, et al.
Blood|November 22, 2012
Clinical drug resistance linked to interconvertible phenotypic and functional states of tumor-propagating cells in multiple myelomaAristeidis Chaidos, Chris P Barnes, Gillian Cowan, et al.
Pageof 1